| A Case of Long-term Remission with Ofatumumab Maintenance-Therapy in Multiply Relapsed and Rituximab-Refractory Chronic Lymphocytic Leukaemia with Deletion 17p. | |
| | |
MedLine Citation:
|
PMID: 23278160 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
We report a 77-year old male patient with chronic lymphocytic leukaemia (CLL), requiring the sixth line of treatment due to relapse with progressive lymphadenopathy, worsening thrombocytopenia and pronounced night sweats. First diagnosis was established 8 years earlier in 2004 with advanced stage disease (Binet C) and a high risk profile consisting in high CD38 and ZAP70 expression. Initial fluorescence-in-situ-hybridization showed deletion 13q in 65% of CLL-cells without other chromosomal aberrations. Previous CLL specific therapies are summarized in table 1. © 2012 John Wiley & Sons A/S. |
| | |
Authors:
|
Namberger Konrad; Weiss Lukas; Krause Barbara; Melchardt Thomas; Greil Richard |
Publication Detail:
|
Type: LETTER Date: 2012-12-28 |
Journal Detail:
|
Title: European journal of haematology Volume: - ISSN: 1600-0609 ISO Abbreviation: Eur. J. Haematol. Publication Date: 2012 Dec |
Date Detail:
|
Created Date: 2013-1-2 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8703985 Medline TA: Eur J Haematol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
© 2012 John Wiley & Sons A/S. |
Affiliation:
|
3rd Medical Department of Haematology, Medical Oncology, Haemostaseology, Rheumatology and Infectious Disease, University Hospital Salzburg, Salzburg, Austria. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Adaptation at range margins: common garden trials and the performance of Arabidopsis lyrata across i...
Next Document: Review article: the diagnosis of non-alcoholic fatty liver disease - availability and accuracy of no...